1. Home
  2. SMX vs RNAZ Comparison

SMX vs RNAZ Comparison

Compare SMX & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMX
  • RNAZ
  • Stock Information
  • Founded
  • SMX N/A
  • RNAZ 2016
  • Country
  • SMX Ireland
  • RNAZ United States
  • Employees
  • SMX N/A
  • RNAZ N/A
  • Industry
  • SMX Industrial Machinery/Components
  • RNAZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • SMX Technology
  • RNAZ Health Care
  • Exchange
  • SMX Nasdaq
  • RNAZ Nasdaq
  • Market Cap
  • SMX 6.7M
  • RNAZ 6.1M
  • IPO Year
  • SMX N/A
  • RNAZ 2021
  • Fundamental
  • Price
  • SMX $4.20
  • RNAZ $7.97
  • Analyst Decision
  • SMX
  • RNAZ Strong Buy
  • Analyst Count
  • SMX 0
  • RNAZ 1
  • Target Price
  • SMX N/A
  • RNAZ $280.00
  • AVG Volume (30 Days)
  • SMX 33.2K
  • RNAZ 32.8K
  • Earning Date
  • SMX 01-01-0001
  • RNAZ 08-13-2025
  • Dividend Yield
  • SMX N/A
  • RNAZ N/A
  • EPS Growth
  • SMX N/A
  • RNAZ N/A
  • EPS
  • SMX N/A
  • RNAZ N/A
  • Revenue
  • SMX N/A
  • RNAZ N/A
  • Revenue This Year
  • SMX N/A
  • RNAZ N/A
  • Revenue Next Year
  • SMX N/A
  • RNAZ N/A
  • P/E Ratio
  • SMX N/A
  • RNAZ N/A
  • Revenue Growth
  • SMX N/A
  • RNAZ N/A
  • 52 Week Low
  • SMX $3.60
  • RNAZ $6.15
  • 52 Week High
  • SMX $1,308.64
  • RNAZ $970.20
  • Technical
  • Relative Strength Index (RSI)
  • SMX 37.98
  • RNAZ 47.04
  • Support Level
  • SMX $3.60
  • RNAZ $7.32
  • Resistance Level
  • SMX $5.28
  • RNAZ $8.48
  • Average True Range (ATR)
  • SMX 0.51
  • RNAZ 0.58
  • MACD
  • SMX 0.04
  • RNAZ 0.41
  • Stochastic Oscillator
  • SMX 31.52
  • RNAZ 70.77

About SMX SMX (Security Matters) Public Limited Company

SMX (Security Matters) PLC provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader, and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.

Share on Social Networks: